Dare Bioscience, Inc. (DARE) Operating margin 2016–2025
Dare Bioscience, Inc. (DARE) operating margin by fiscal year — reported operating income divided by reported revenue.
-1315.5%FY2025 · since FY2016: -82.3% → -1315.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1315.5% | +238376.7 pp |
| FY2024 | -239692.2% | -238590.3 pp |
| FY2023 | -1101.9% | -788.0 pp |
| FY2022 | -313.9% | — |
| FY2016 | -82.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More DARE financial trends
DARE RevenueDARE Net incomeDARE Net marginDARE Gross profitDARE Gross marginDARE Operating incomeDARE Operating cash flowDARE Free cash flowDARE Capital expendituresDARE Return on equityDARE Stock buybacksDARE Dividends paidDARE Total assetsDARE Total liabilitiesDARE Shareholders’ equityDARE overview →